Stuart, FL (July 30, 2024) – Linical, a global Contract Research Organization (CRO) for full-service drug development, has named Clareece West as President of Linical’s American and European regions. Ms. West will lead the organization’s western region, overseeing clinical operations, medical affairs, sales, marketing, proposals, finance, human resources, information technology, and compliance. Additionally, she will help drive Linical’s strategic growth to align with client needs, including expanding the organization’s global coverage and integrating industry-leading technologies.
Ms. West possesses over 20 years of executive leadership experience including laboratory medicine, healthcare technology and global clinical and commercial operations across numerous therapeutic areas, and diverse responsibilities including change management, international sales, proposals, marketing, mergers & acquisitions, profit & loss statements, and restructuring expertise. She has worked in global leadership positions across healthcare technology, two Fortune Top 10 organizations, and two top 5 CROs. She has a track record in integrating global teams, expanding strategic partnerships, and driving growth in market share to achieve corporate goals.
“Clareece's extensive experience and unwavering drive make her the ideal leader to guide Linical into a new era of growth,” said Kazuhiro Hatano, CEO and Co-Founder, Linical Co Ltd. “Her expertise and vision will be instrumental in steering our strategic direction and ensuring the continued success of our operations.”
Ms. West recently served on the American Red Cross (Greater Kansas City Northwest Missouri) Board of Directors and was active as the Vice President of the Healthcare Business Women Association Board of Directors (Kansas City Region). She also sat on the Board of Directors for Voxello, a medical technology company.
About Linical
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across all major markets including North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, neurology & psychiatry, immunology & vaccine, and endocrinology & metabolic diseases.
Media Contact
Alison Cundari
Senior Director, Marketing & Corporate Communications
acundari@linical.com